DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancerKai Xu, Bin Lang, Yiming Zhang et al.|Aging|2020Cited by 28
A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC).Abai Xu, Chunxiao Liu, Peng Xu et al.|Journal of Clinical Oncology|2023Cited by 1